Shingo Shoji
Fujisawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Phase I Study of Rogocekib in Patients with Advanced, Relapsed, or Refractory Malignant Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 23, 2025
Phase 1 study of rogocekib in patients with relapsed or refractory hematologic malignancies.
Journal: Blood advances
Published: June 30, 2025
Risk of insulin initiation with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: A real-world claims database study in Japan.
Journal: Diabetes, obesity & metabolism
Published: September 20, 2024
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.
Journal: Journal of diabetes investigation
Published: June 29, 2023
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
Journal: Journal of diabetes investigation
Published: August 25, 2022
Demographic and clinical characteristics of patients with type 1 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors in Japan: A real-world administrative database analysis.
Journal: Diabetes research and clinical practice
Published: April 06, 2022
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan.
Journal: Journal of diabetes investigation
Published: October 20, 2021
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: October 08, 2019
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: March 27, 2019
Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling.
Journal: The journal of trauma and acute care surgery
Published: May 25, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026